XULTOPHY 100 unités/ml + 3,6 mg/ml, solution injectable
solution injectable
sous-cutanée
Autorisation active
Procédure centralisée
Commercialisée
9/18/2014
NOVO NORDISK (DANEMARK)
Business Listing - September 04, 2021
This is a premium business listing. Stand out from the competition!